Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · IEX Real-Time Price · USD
218.24
-0.34 (-0.16%)
At close: Jul 19, 2024, 4:00 PM
218.34
+0.10 (0.05%)
After-hours: Jul 20, 2024, 12:58 PM EDT
CRL Revenue
Charles River Laboratories International had revenue of $4.11B in the twelve months ending March 30, 2024, with 0.49% growth year-over-year. Revenue in the quarter ending March 30, 2024 was $1.01B. In the year 2023, Charles River Laboratories International had annual revenue of $4.13B with 3.86% growth.
Revenue (ttm)
$4.11B
Revenue Growth
+0.49%
P/S Ratio
2.73
Revenue / Employee
$188,605
Employees
21,800
Market Cap
11.24B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 30, 2023 | 4.13B | 153.35M | 3.86% |
Dec 31, 2022 | 3.98B | 435.90M | 12.31% |
Dec 25, 2021 | 3.54B | 616.23M | 21.08% |
Dec 26, 2020 | 2.92B | 302.71M | 11.55% |
Dec 28, 2019 | 2.62B | 355.13M | 15.67% |
Dec 29, 2018 | 2.27B | 408.50M | 21.99% |
Dec 30, 2017 | 1.86B | 176.17M | 10.48% |
Dec 31, 2016 | 1.68B | 318.13M | 23.34% |
Dec 26, 2015 | 1.36B | 65.64M | 5.06% |
Dec 27, 2014 | 1.30B | 132.13M | 11.34% |
Dec 28, 2013 | 1.17B | 36.00M | 3.19% |
Dec 29, 2012 | 1.13B | -13.12M | -1.15% |
Dec 31, 2011 | 1.14B | 9.23M | 0.81% |
Dec 25, 2010 | 1.13B | -38.23M | -3.26% |
Dec 26, 2009 | 1.17B | -123.66M | -9.55% |
Dec 27, 2008 | 1.30B | 64.67M | 5.26% |
Dec 29, 2007 | 1.23B | 172.24M | 16.27% |
Dec 30, 2006 | 1.06B | 65.06M | 6.55% |
Dec 31, 2005 | 993.33M | 269.11M | 37.16% |
Dec 25, 2004 | 724.22M | 110.50M | 18.00% |
Dec 27, 2003 | 613.72M | 59.09M | 10.65% |
Dec 28, 2002 | 554.63M | 89.00M | 19.11% |
Dec 29, 2001 | 465.63M | 159.05M | 51.88% |
Dec 30, 2000 | 306.59M | 75.17M | 32.48% |
Dec 25, 1999 | 231.41M | 26.35M | 12.85% |
Dec 26, 1998 | 205.06M | 34.35M | 20.12% |
Dec 27, 1997 | 170.71M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fresenius Medical Care AG & Co. KGaA | 21.17B |
Universal Health Services | 14.66B |
DaVita | 12.34B |
Smith & Nephew | 5.55B |
Catalent | 4.14B |
Teleflex | 3.00B |
Globus Medical | 1.90B |
Bio-Techne | 1.15B |
CRL News
- 5 days ago - Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call - Business Wire
- 5 days ago - CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories' Directors and Officers for Breach of Fiduciary Duties - GlobeNewsWire
- 14 days ago - Charles River to Perform Plasmid Manufacturing for AAVantgarde - Business Wire
- 27 days ago - Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus - Business Wire
- 5 weeks ago - Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy - Business Wire
- 5 weeks ago - Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives - Business Wire
- 6 weeks ago - Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville - Business Wire
- 6 weeks ago - Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research - Business Wire